| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066828a4b6f7a816447cb8ba1bcbb40e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
| filingDate |
1986-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_230c13648804bfeabde9350e7f486021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dc2d2142aaaddfb83551618d108d2cc |
| publicationDate |
1986-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0203909-A1 |
| titleOfInvention |
Early-summer meningo-encephalitis virus (FSME-virus) vaccine, and method of producing the same |
| abstract |
An early summer meningoencephalitis virus (TBE virus) vaccine is described which contains glycoprotein E in an immunogenic form in an inactivated preparation of the TBE virus, and a method for its production. Since not all structural proteins present in the virus are necessary for the induction of protective immunity, a suspension containing the virus is treated with a detergent or an organic solvent, the virus dissociating and the protective glycoprotein E being contained as the active component. Before or after the dissociation or solubilization, inactivation with formalin or β-propiolactone is carried out; isolation of the glycoprotein E can be carried out by additional fractionation measures, with non-protective protein components being separated off. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-402897-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0431129-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9217570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0431129-A1 |
| priorityDate |
1985-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |